×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | 3.25 | -4.52 | NA | -18.44 | 0 | |
| EVEREST ORGANICS LTD. | 411.51 | 29.13 | 409.35 | 1.35 | 391.0 | |
| ZENOTECH LABORATORIES LTD. | 126.24 | 12.30 | 111.13 | 0.00 | 363 | 87.2 |
| SMS Lifesciences India Ltd | 876.27 | 26.75 | 854.28 | 8.85 | 337 | 18.0 |
Everest Organics Ltd., with Security Code 524790, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 43.3 | 50.8 | 42.7 | 49.4 | 52.5 | 52.6 | 32.4 | 44.0 | 42.1 | 40.9 |
| Expenses | 45.8 | 48.5 | 40.1 | 46.7 | 49.7 | 49.7 | 36.1 | 40.6 | 38.0 | 37.5 |
| Operating Profit | -2.5 | 2.3 | 2.5 | 2.7 | 2.8 | 3.0 | -3.7 | 3.4 | 4.0 | 3.4 |
| OPM % | -5.75% | 4.49% | 5.91% | 5.48% | 5.33% | 5.63% | -11.27% | 7.78% | 9.55% | 8.4% |
| Other Income | 5.6 | 0.7 | 0.2 | 0.2 | 0.1 | 0.3 | 0.3 | 0.1 | 0.0 | 0.2 |
| Interest | 0.8 | 1.0 | 1.3 | 1.5 | 1.4 | 1.2 | 1.3 | 1.4 | 1.4 | 1.1 |
| Depreciation | 1.1 | 1.3 | 1.3 | 1.3 | 1.3 | 1.9 | 1.5 | 1.5 | 1.5 | 1.6 |
| Profit before tax | 1.2 | 0.8 | 0.2 | 0.1 | 0.2 | 0.2 | -6.1 | 0.7 | 1.2 | 1.0 |
| Tax % | 21.9% | -85% | -78% | -78.3% | -89.4% | -64.2% | 0% | -0.9% | -0.9% | 200.2% |
| Net Profit | 1.5 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | -6.1 | 0.7 | 1.1 | 2.9 |
| EPS in Rs | 1.9 | 0.14 | 0.04 | 0.04 | 0.02 | 0.07 | -7.61 | 0.93 | 1.42 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 5% |
| 3 Years: | 3% |
| TTM: | -12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -15% |
| 5 Years: | -55% |
| 3 Years: | -78% |
| TTM: | -2170% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 35% |
| 3 Years: | 39% |
| 1 Year: | 238% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|